JP2004522555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004522555A5 JP2004522555A5 JP2003513456A JP2003513456A JP2004522555A5 JP 2004522555 A5 JP2004522555 A5 JP 2004522555A5 JP 2003513456 A JP2003513456 A JP 2003513456A JP 2003513456 A JP2003513456 A JP 2003513456A JP 2004522555 A5 JP2004522555 A5 JP 2004522555A5
- Authority
- JP
- Japan
- Prior art keywords
- sis
- layer
- tissue
- ecm
- bioprosthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001519 tissue Anatomy 0.000 claims description 139
- 239000000463 material Substances 0.000 claims description 120
- 238000000034 method Methods 0.000 claims description 39
- 239000006260 foam Substances 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 21
- 230000003014 reinforcing effect Effects 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000011165 3D composite Substances 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 239000002657 fibrous material Substances 0.000 claims description 6
- 229910010272 inorganic material Inorganic materials 0.000 claims description 6
- 239000011147 inorganic material Substances 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 239000000314 lubricant Substances 0.000 claims description 5
- 210000002469 basement membrane Anatomy 0.000 claims description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 claims description 4
- 210000003932 urinary bladder Anatomy 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 239000002759 woven fabric Substances 0.000 claims description 3
- 210000005000 reproductive tract Anatomy 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 239000010410 layer Substances 0.000 description 162
- 239000000835 fiber Substances 0.000 description 52
- 210000004027 cell Anatomy 0.000 description 35
- 230000015572 biosynthetic process Effects 0.000 description 23
- 238000003786 synthesis reaction Methods 0.000 description 22
- 230000002787 reinforcement Effects 0.000 description 21
- 210000004872 soft tissue Anatomy 0.000 description 15
- 239000002131 composite material Substances 0.000 description 13
- 239000004626 polylactic acid Substances 0.000 description 12
- 229920001610 polycaprolactone Polymers 0.000 description 11
- 239000004632 polycaprolactone Substances 0.000 description 11
- 210000004876 tela submucosa Anatomy 0.000 description 11
- 229920000747 poly(lactic acid) Polymers 0.000 description 10
- 230000008439 repair process Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 8
- 210000003041 ligament Anatomy 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 210000002744 extracellular matrix Anatomy 0.000 description 7
- 239000007943 implant Substances 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 230000000399 orthopedic effect Effects 0.000 description 6
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 6
- 239000000622 polydioxanone Substances 0.000 description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 239000002250 absorbent Substances 0.000 description 5
- 230000002745 absorbent Effects 0.000 description 5
- 210000000845 cartilage Anatomy 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- -1 BMP-12 Proteins 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 229920000249 biocompatible polymer Polymers 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000004633 polyglycolic acid Substances 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 239000004753 textile Substances 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 239000012867 bioactive agent Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000001612 chondrocyte Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 3
- 238000009941 weaving Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 229920002971 Heparan sulfate Chemical group 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012783 reinforcing fiber Substances 0.000 description 2
- 210000000513 rotator cuff Anatomy 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 210000002536 stromal cell Anatomy 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000007838 tissue remodeling Effects 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 241001125840 Coryphaenidae Species 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- 102000004237 Decorin Human genes 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000722985 Fidia Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 1
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 1
- 108090000031 Hedgehog Proteins Proteins 0.000 description 1
- 102000003693 Hedgehog Proteins Human genes 0.000 description 1
- 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
- 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
- 101000886562 Homo sapiens Growth/differentiation factor 8 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 241000287463 Phalacrocorax Species 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004792 Prolene Substances 0.000 description 1
- 102100028965 Proteoglycan 4 Human genes 0.000 description 1
- 241000359034 Stromanthe sanguinea Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000005068 bladder tissue Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229940112869 bone morphogenetic protein Drugs 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940089982 healon Drugs 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 238000013150 knee replacement Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 210000004523 ligament cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 108010009030 lubricin Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000117 poly(dioxanone) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 108010070228 surgisis Proteins 0.000 description 1
- 229940036220 synvisc Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30578601P | 2001-07-16 | 2001-07-16 | |
| US09/918,116 US6638312B2 (en) | 2000-08-04 | 2001-07-30 | Reinforced small intestinal submucosa (SIS) |
| US10/172,347 US8366787B2 (en) | 2000-08-04 | 2002-06-14 | Hybrid biologic-synthetic bioabsorbable scaffolds |
| PCT/US2002/022364 WO2003007847A1 (en) | 2001-07-16 | 2002-07-15 | Hybrid biologic-synthetic bioabsorable scaffolds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004522555A JP2004522555A (ja) | 2004-07-29 |
| JP2004522555A5 true JP2004522555A5 (enExample) | 2008-09-04 |
| JP4197159B2 JP4197159B2 (ja) | 2008-12-17 |
Family
ID=27390127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003513456A Expired - Fee Related JP4197159B2 (ja) | 2001-07-16 | 2002-07-15 | 混成の生物学的合成の生体吸収性支持骨格材料 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1416878A4 (enExample) |
| JP (1) | JP4197159B2 (enExample) |
| AU (1) | AU2002320517B2 (enExample) |
| WO (1) | WO2003007847A1 (enExample) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69821127T2 (de) | 1997-02-13 | 2004-06-09 | Boston Scientific Ltd., St. Michael | Perkutane und hiatale geräte zur verwendung bei minimal invasiver beckenchirurgie |
| CA2365376C (en) | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| EP2292182A1 (en) | 2001-03-09 | 2011-03-09 | Boston Scientific Limited | System for implanting an implant |
| US9149261B2 (en) | 2001-03-09 | 2015-10-06 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to delivery of medical implants |
| US6666817B2 (en) | 2001-10-05 | 2003-12-23 | Scimed Life Systems, Inc. | Expandable surgical implants and methods of using them |
| DE60330860D1 (de) | 2002-06-12 | 2010-02-25 | Boston Scient Ltd The Corporat | Medizinische schlinge |
| US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| WO2004060206A1 (en) | 2002-12-17 | 2004-07-22 | Boston Scientific Limited | Spacer for sling delivery system |
| US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| GB0307011D0 (en) | 2003-03-27 | 2003-04-30 | Regentec Ltd | Porous matrix |
| US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| US7361138B2 (en) | 2003-07-31 | 2008-04-22 | Scimed Life Systems, Inc. | Bioabsorbable casing for surgical sling assembly |
| US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| CA2535594A1 (en) | 2003-08-14 | 2005-02-24 | Jamie Li | Surgical slings |
| US8545386B2 (en) | 2003-08-14 | 2013-10-01 | Boston Scientific Scimed, Inc. | Surgical slings |
| EP2740416B1 (en) | 2003-10-03 | 2021-05-05 | Boston Scientific Limited, an Irish company | Systems for a delivering a medical implant to an anatomical location in a patient |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| US8221780B2 (en) | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8657881B2 (en) * | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
| US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| EP1765218B1 (en) | 2004-06-14 | 2014-06-11 | Boston Scientific Limited | An implantable sling for treating urinary incontinence |
| US8329202B2 (en) | 2004-11-12 | 2012-12-11 | Depuy Products, Inc. | System and method for attaching soft tissue to an implant |
| US7556598B2 (en) | 2005-04-04 | 2009-07-07 | Boston Scientific Scimed, Inc. | Dissolvable protective treatment for an implantable supportive sling |
| ES2536748T3 (es) | 2005-04-06 | 2015-05-28 | Boston Scientific Limited | Sistemas y dispositivos para tratar trastornos del suelo pélvico |
| EP1909687A1 (en) | 2005-07-13 | 2008-04-16 | Boston Scientific Scimed, Inc. | Snap fit sling anchor system and related methods |
| US7981023B2 (en) | 2005-07-25 | 2011-07-19 | Boston Scientific Scimed, Inc. | Elastic sling system and related methods |
| US7878969B2 (en) | 2005-07-25 | 2011-02-01 | Boston Scientific Scimed, Inc. | Pelvic floor repair system |
| US8033982B2 (en) | 2005-08-03 | 2011-10-11 | Boston Scientific Scimed, Inc. | Systems, devices and methods relating to a shape resilient sling-like support for treating urinary incontinence |
| US7935046B2 (en) | 2005-08-11 | 2011-05-03 | Boston Scientific Scimed, Inc. | Systems, methods and devices relating to a removable sleeve for an implantable sling |
| US7951066B2 (en) | 2005-08-17 | 2011-05-31 | Boston Scientific Scimed, Inc. | Medical device positioning assemblies and methods |
| US7699769B2 (en) | 2005-09-01 | 2010-04-20 | Boston Scientific Scimed, Inc. | Adjustable surgical sling |
| RU2289361C1 (ru) * | 2005-12-12 | 2006-12-20 | Ооо "Дона-М" | Эндопротез для замещения поврежденных связок и сухожилий |
| EP3505137A1 (en) * | 2006-05-09 | 2019-07-03 | LifeCell Corporation | Reinforced biological tissue |
| US20100204775A1 (en) * | 2006-05-22 | 2010-08-12 | Tarun John Edwin | Tissue Synthetic- Biomaterial Hybrid Medical Devices |
| US8524265B2 (en) * | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
| US20090157193A1 (en) * | 2007-12-18 | 2009-06-18 | Warsaw Orthopedic, Inc. | Tendon and Ligament Repair Sheet and Methods of Use |
| US20130116799A1 (en) | 2008-03-27 | 2013-05-09 | The Cleveland Clinic Foundation | Reinforced tissue graft |
| WO2009120966A2 (en) | 2008-03-27 | 2009-10-01 | The Cleveland Clinic Foundation | Reinforced tissue graft |
| CN101332134B (zh) * | 2008-07-15 | 2012-01-11 | 许和平 | I型胶原人工肌腱、韧带的制备及应用 |
| EP2907531A1 (en) * | 2008-07-30 | 2015-08-19 | Mesynthes Limited | Method of separating or decellularising layers of tissue |
| FR2937243B1 (fr) * | 2008-10-22 | 2011-11-18 | Sofradim Production | Implant de renfort |
| US8470355B2 (en) * | 2009-10-01 | 2013-06-25 | Covidien Lp | Mesh implant |
| US8758800B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
| US8758798B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
| US8758799B2 (en) | 2010-03-24 | 2014-06-24 | Covidien Lp | Therapeutic implant |
| CN103249375A (zh) * | 2010-06-09 | 2013-08-14 | 瑞士商麦斯特医疗股份有限公司 | 抗沾粘外科入路、加固性与封闭假体 |
| FR2962646B1 (fr) | 2010-07-16 | 2012-06-22 | Sofradim Production | Prothese avec element radio-opaque |
| US9861590B2 (en) | 2010-10-19 | 2018-01-09 | Covidien Lp | Self-supporting films for delivery of therapeutic agents |
| US9017711B2 (en) | 2011-04-28 | 2015-04-28 | Warsaw Orthopedic, Inc. | Soft tissue wrap |
| US9113991B2 (en) | 2011-05-12 | 2015-08-25 | Boston Scientific Scimed, Inc. | Anchors for bodily implants and methods for anchoring bodily implants into a patient's body |
| US9636201B2 (en) | 2011-05-12 | 2017-05-02 | Boston Scientific Scimed, Inc. | Delivery members for delivering an implant into a body of a patient |
| FR2977790B1 (fr) | 2011-07-13 | 2013-07-19 | Sofradim Production | Prothese pour hernie ombilicale |
| US8579924B2 (en) | 2011-07-26 | 2013-11-12 | Covidien Lp | Implantable devices including a mesh and a pivotable film |
| GB201113303D0 (en) | 2011-08-02 | 2011-09-14 | Xiros Ltd | Connective tissue repair pad |
| US9782957B2 (en) | 2011-08-24 | 2017-10-10 | Covidien Lp | Medical device films |
| US9179994B2 (en) | 2011-10-25 | 2015-11-10 | Covidien Lp | Implantable film/mesh composite |
| US8932621B2 (en) | 2011-10-25 | 2015-01-13 | Covidien Lp | Implantable film/mesh composite |
| US9005308B2 (en) | 2011-10-25 | 2015-04-14 | Covidien Lp | Implantable film/mesh composite for passage of tissue therebetween |
| US10206769B2 (en) | 2012-03-30 | 2019-02-19 | Covidien Lp | Implantable devices including a film providing folding characteristics |
| FR2992662B1 (fr) | 2012-06-28 | 2014-08-08 | Sofradim Production | Tricot avec picots |
| FR2992547B1 (fr) | 2012-06-29 | 2015-04-24 | Sofradim Production | Prothese pour hernie |
| GB201301784D0 (en) | 2013-02-01 | 2013-03-20 | Xiros Ltd | Connective tissue repair technology |
| DK3237028T3 (da) * | 2014-12-22 | 2021-03-22 | Aroa Biosurgery Ltd | Lamineret vævstransplantatprodukt |
| CA3007935A1 (en) * | 2015-12-11 | 2017-06-15 | Poly-Med, Inc. | Synthetic implant device replicating natural tissue structure and methods of making same |
| US11484401B2 (en) | 2016-02-01 | 2022-11-01 | Medos International Sarl | Tissue augmentation scaffolds for use in soft tissue fixation repair |
| US20170273680A1 (en) | 2016-02-01 | 2017-09-28 | DePuy Synthes Products, Inc. | Tissue augmentation tacks for use with soft tissue fixation repair systems and methods |
| US20170215864A1 (en) | 2016-02-01 | 2017-08-03 | DePuy Synthes Products, Inc. | Tissue augmentation constructs for use with soft tissue fixation repair systems and methods |
| CN105664257B (zh) * | 2016-03-01 | 2019-02-19 | 上海卓阮医疗科技有限公司 | 一种修复区稳固的复合软组织修复材料 |
| CN109331229A (zh) * | 2018-11-28 | 2019-02-15 | 上海白衣缘生物工程有限公司 | 一种医用生物线、医用生物修补网片及其制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1405886A (en) | 1971-11-01 | 1975-09-10 | Astra Laekemedel Ab | Synergistic compositions comprising penicillin and cephalosporin antibiotics |
| US4352463A (en) | 1979-01-18 | 1982-10-05 | Leisure Lawn, Inc. | Motorized combination wet and dry lawn treatment spreader |
| US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5800537A (en) * | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
| US5275826A (en) | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| DE4302709C1 (de) * | 1993-02-01 | 1994-07-28 | Kirsch Axel | Abdeckeinrichtung mit Abdeckmembran |
| WO1995005083A1 (en) * | 1993-08-13 | 1995-02-23 | Smith & Nephew Richards Inc | Microporous polymeric foams and microtextured surfaces |
| EP0677297B1 (en) * | 1993-09-24 | 2000-12-13 | Takiron Co. Ltd. | Implantation material |
| GB2282328B (en) * | 1993-09-29 | 1997-10-08 | Johnson & Johnson Medical | Absorbable structures for ligament and tendon repair |
| WO1995019796A1 (en) * | 1994-01-21 | 1995-07-27 | Brown University Research Foundation | Biocompatible implants |
| AU2369695A (en) * | 1994-04-29 | 1995-11-29 | W.L. Gore & Associates, Inc. | Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same |
| ATE219343T1 (de) * | 1994-04-29 | 2002-07-15 | Scimed Life Systems Inc | Stent mit kollagen |
| US5709934A (en) * | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
| US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| GB9721585D0 (en) * | 1997-10-10 | 1997-12-10 | Geistlich Soehne Ag | Chemical product |
| US5855613A (en) * | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
| US5965125A (en) * | 1995-10-25 | 1999-10-12 | Transkaryotic Therapies, Inc. | Hybrid matrix implants and explants |
| US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US5755791A (en) * | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
| FR2766717B1 (fr) * | 1997-08-01 | 2000-06-09 | Cogent Sarl | Prothese composite pour la prevention des adherences post-chirurgicales et son procede d'obtention |
| US6409764B1 (en) * | 1998-12-03 | 2002-06-25 | Charles F. White | Methods and articles for regenerating bone or peridontal tissue |
-
2002
- 2002-07-15 AU AU2002320517A patent/AU2002320517B2/en not_active Ceased
- 2002-07-15 JP JP2003513456A patent/JP4197159B2/ja not_active Expired - Fee Related
- 2002-07-15 WO PCT/US2002/022364 patent/WO2003007847A1/en not_active Ceased
- 2002-07-15 EP EP02750038A patent/EP1416878A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4197159B2 (ja) | 混成の生物学的合成の生体吸収性支持骨格材料 | |
| JP2004522555A5 (enExample) | ||
| US8366787B2 (en) | Hybrid biologic-synthetic bioabsorbable scaffolds | |
| US7569233B2 (en) | Hybrid biologic-synthetic bioabsorbable scaffolds | |
| US20220331491A1 (en) | Scaffolds with viable tissue | |
| US20050249772A1 (en) | Hybrid biologic-synthetic bioabsorbable scaffolds | |
| US7914808B2 (en) | Hybrid biologic/synthetic porous extracellular matrix scaffolds | |
| US8025896B2 (en) | Porous extracellular matrix scaffold and method | |
| US7163563B2 (en) | Unitary surgical device and method | |
| US7201917B2 (en) | Porous delivery scaffold and method | |
| US7871440B2 (en) | Unitary surgical device and method | |
| JP4294474B2 (ja) | 半月板再生装置 | |
| US7361195B2 (en) | Cartilage repair apparatus and method | |
| AU2002320517A1 (en) | Hybrid biologic-synthetic bioabsorable scaffolds | |
| US20040166169A1 (en) | Porous extracellular matrix scaffold and method | |
| AU2002316694A1 (en) | Hybrid biologic/synthetic porous extracellular matrix scaffolds | |
| AU2005201800A1 (en) | Hybrid biologic-synthetic bioabsorbable scaffolds | |
| EP1416876B1 (en) | Porous delivery scaffold and method | |
| AU2005201981A1 (en) | Hybrid biologic-synthetic bioabsorbable scaffolds | |
| AU2002354912B2 (en) | Porous delivery scaffold and method | |
| AU2002354912A1 (en) | Porous delivery scaffold and method |